0004, VZV IGG and controls
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- W81K0220D0019
- Awardee
-
Diasorin Inc. UEI FGK2QR959BV5 Part of Diasorin S.P.A.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Task orders
- 5 $346,799 obligated
Award facts
- Opportunity
-
- Automated ID serology analyzer Pre-Solicitation · W81K0220Q0128 · Posted May 12, 2020
- Automated ID serology analyzer Award Notice · Posted Sep 29, 2020
- Automated ID serology analyzer Solicitation · Posted Aug 10, 2020
- Combined order value
- $346,799 Current and potential, with all options
- Last date to order 100% complete
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- 6 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Diasorin Inc., a Minnesota-based subsidiary of Italian-owned Diasorin S.P.A., with a ceiling value of $321,055.77 and an ultimate completion date of September 30, 2025. The contract was awarded on October 1, 2020, without socioeconomic set-aside designation. The primary deliverables under this indefinite delivery vehicle consist of varicella zoster virus (VZV) immunoglobulin G (IgG) reagents and controls, with modifications to part numbers and quantities throughout the contract performance period. Diasorin Inc. specializes in chemiluminescence immunoassay analyzers and diagnostic reagents for infectious disease testing, providing the Defense Health Agency with laboratory diagnostic solutions that support medical facilities requiring comprehensive infectious disease detection capabilities. The contract represents part of Diasorin's broader federal contract portfolio with the Defense Health Agency, which includes multiple indefinite delivery contracts valued at approximately $540,000 for LIAISON test kits and supplies through September 2030.
Five delivery orders have been issued against this indefinite delivery vehicle from October 1, 2021, through October 1, 2024, with individual order values ranging from $57,089.76 to $85,364.46. Performance locations include Lewis-McChord, Washington (a major Department of Defense installation with medical facilities), Stillwater, Minnesota (Diasorin's principal place of business), and Madigan Army Medical Center in Washington. Each delivery order was structured as a firm fixed-price contract with no set-aside designation, reflecting the government's assessment of Diasorin's specialized technical capabilities in infectious disease diagnostics. The most recent delivery order, issued on October 1, 2024, incorporated modifications to item numbers and quantities while adding Fiscal Year 2025 funding, with performance concluding by September 30, 2025. As prime contractor, Diasorin Inc. performs substantially all work without identified subcontractors, delivering reagent supplies directly to federal healthcare facilities requiring varicella zoster virus immunological testing capabilities for patient diagnostic operations.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Reagents OPT 4 task order | Medical Command (Army) | $85,364 | |
| 3005 liaison VZV IGG | Medical Command (Army) | $85,364 | |
| A cost per test, lease, contract for reagents and automated or semi-automated instrumentation for the detection of… | Medical Command (Army) | $59,490 | |
| 1003, VZV IGG and controls | Medical Command (Army) | $59,490 | |
| 0003, VZV IGG and controls | Medical Command (Army) | $57,090 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Change Order | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W81K0220D0019?
W81K0220D0019 was awarded to Diasorin Inc. by Medical Command (Department of the Army) on October 1, 2020.
How much is contract W81K0220D0019 worth?
Orders under W81K0220D0019 have obligated $346,799.
How many orders have been placed under contract W81K0220D0019?
5 orders have been placed under W81K0220D0019, the latest on October 1, 2024.
Which agency awarded contract W81K0220D0019?
Medical Command (Department of the Army) awarded W81K0220D0019, with funding from Defense Health Agency (Department of Defense).
Who can order from contract W81K0220D0019?
W81K0220D0019 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W81K0220D0019 competed?
The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV